Overview

Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage

Status:
Unknown status
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks regimen with placebo.A stool culture will be performed every week for 5 weeks (during the administration of treatment) then every two weeks until 3 consecutive negative stool culture for VRE.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Treatments:
Vancomycin